"DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9" by Traci L Hilton

Selected Works of Walter J. Urba, MD, PhD

Article

DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9

Journal for ImmunoTherapy of Cancer (2013)

Traci L Hilton
Tyler W Hulett, Oregon Health & Science University
Chistopher Dubay
Rieneke van de Ven, VU University Medical Center
Sandra Aung
Walter J Urba, Providence Portland Medical Center
Hong Ming Hu, Providence Portland Medical Center
Bernard A Fox, Oregon Health & Science University

Link

Disciplines

Publication Date

January 1, 2013

DOI

10.1186/2051-1426-1-S1-P260

Citation Information

Traci L Hilton, Tyler W Hulett, Chistopher Dubay, Rieneke van de Ven, et al.. "DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9" Journal for ImmunoTherapy of Cancer Vol. 1 Iss. 1 (2013) p. 260
Available at: http://works.bepress.com/walter-urba/153/